Vertex Pharmaceuticals said it has dropped development of an mRNA-based cystic fibrosis therapy, after facing challenges delivering the genetic medicine similar to those that have

The FDA has narrowed its search for a new leader of its Center for Biologics Evaluation and Research to three to four final candidates, according

The Supreme Court restored mail ordering of mifepristone reversing a federal appeals court’s stay. The decision Monday came after makers of the pill asked for

Celcuity’s breast cancer drug wins again: The company said two regimens with its experimental drug gedatolisib succeeded in PIK3CA mutant patients as part of its

A new flavor of company is shaking up how biotechs are built. Instead of launching with eye-popping early-stage science or a new platform, there’s a